Open the mobile version, with barcode scanning
Class II Terminated

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufact…

Why: Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.

Company
Teva Pharmaceuticals USA
North Wales, PA, United States
Reported
Feb 22, 2017
Recall started
Feb 2, 2017
Ended
Feb 6, 2018
Where sold
Nationwide in the United States
Amount
17,473 cartons
Full product description
Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.
Lots / codes affected
Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.